The impact of a closed, intravenous medication system for a neonatal intensive care unit


Intravenous literature: Tanner, J. (2012) Developing a Closed, Intravenous Medication System for a Neonatal Intensive Care Unit. Neonatal Intensive Care. 25(4), p.21-24.

Sample text:

“The quality of neonatal intensive care is reliant upon a blend of nursing competency, techniques, and technologies each developed specifically for a specialized and fragile patient population. The importance of intravenous medication therapy in the care of these delicate patients is especially critical to their survival. Yet complications that arise from intravenous administration of medications and nutrition are a primary source of serious iatrogenic events such as medication errors and hospital-acquired bloodstream infections. Critically ill, premature infants are especially vulnerable to bloodstream infections (BSIs), because of their immature immune systems, their poor skin integrity, repeated invasive procedures, exposure to numerous caregivers, and being in an environment conducive to bacterial colonization.”

Main page


Comments are closed.